Johnson & Johnson’s (JNJ) offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue (KVUE) common stock owned by Johnson & Johnson was oversubscribed. 8.0324 shares of Kenvue common stock will be exchanged for each share of Johnson & Johnson common stock accepted in the exchange offer. 802,707,331 shares of Johnson & Johnson common stock were tendered, including 250,407,279 shares that were tendered by notice of guaranteed delivery. Johnson & Johnson intends to accept 190,955,436 of the tendered shares in exchange for the 1,533,830,450 shares of Kenvue common stock owned by Johnson & Johnson. Because the exchange offer was oversubscribed, Johnson & Johnson is accepting only a portion of the shares of its common stock, on a pro rata basis in proportion to the number of shares tendered. It is estimated that approximately 23.8% of the tendered shares of Johnson & Johnson common stock will be exchanged. Johnson & Johnson expects to announce the final proration factor on August 23. Following the completion of the exchange offer, Johnson & Johnson will retain approximately 9.5% of the outstanding shares of Kenvue common stock.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on JNJ:
- Notable open interest changes for August 18th
- Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call
- Notable open interest changes for August 17th
- Johnson & Johnson says final exchange ratio 8.0324 in split-off of Kenvue
- Cantor biotech/biopharma analysts to hold analyst/industry conference call